Dana-Farber Research Supports FDA Approval of New Therapy for "Double-Positive" Metastatic Breast Cancer
July 06, 2026
July 06, 2026
BOSTON, Massachusetts, July 6 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Dana-Farber Research Supports FDA Approval of New Therapy for "Double-Positive" Metastatic Breast Cancer
*
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led b . . .
* * *
Dana-Farber Research Supports FDA Approval of New Therapy for "Double-Positive" Metastatic Breast Cancer
*
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led b . . .